Drug profile · INN
rucaparib
RUBRACA
rucaparib (RUBRACA) is a parp 1, 2 and 3 inhibitor.
EMA: approved Antineoplastic and immunomodulating agents (L01) L01XX
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — rucaparib
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
rucaparib (RUBRACA) is a parp 1, 2 and 3 inhibitor.
Key facts
INN rucaparib
Brand RUBRACA
Mechanism PARP 1, 2 and 3 inhibitor
Target PARP 1, 2 and 3
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XX
Mechanism of action
PARP 1, 2 and 3 inhibitor
Primary target: PARP 1, 2 and 3
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is rucaparib?
rucaparib (RUBRACA) is a parp 1, 2 and 3 inhibitor.
What is the brand name for rucaparib?
RUBRACA is a marketed brand name for rucaparib. Check FDA Drugs@FDA for the current US label holder and prescribing information.